ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Faced Pressure From Congress, HHS, White On Mammography Statement

April 11, 1997

House committee Seeks $239 Million Cut In Clinton’s NIH Budget

March 11, 1994

NCCS Networker Volume 9 Issue 4, Winter 1995

January 12, 1995

President’s Budget Request for FDA Omits Funding for Critical Path.

February 8, 2008

Toxicity Testing Reorganization Announced; Rall To Head It Up

November 17, 1978

Broder Emerges As National Leader In ASCO Talk, Calls For Faster Reporting Of Clinical

June 2, 1989